Sign In  |  Register  |  About Sunnyvale  |  Contact Us

Sunnyvale, CA
September 01, 2020 10:10am
7-Day Forecast | Traffic

  • Search Hotels in Sunnyvale

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

748.01 -1.91 (-0.25%)
Official Closing Price Updated: 7:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2
...
18 19 20 21 22 23 24 25 26
...
99 100 Next >
These 4 Vanguard ETFs Soared Over 20% in the First Half of 2024. Here's Which One Is Most Likely to Fly Even Higher.
These Vanguard ETFs have a lot in common. 
Via The Motley Fool
Topics ETFs
Eli Lilly Shares Gain After Drug-Maker Gets FDA's Nod For Early Alzheimer's Treatment
The treatment is intended for adults in the early symptomatic stages of Alzheimer's disease. 
Via Benzinga
Exposures Product Safety
Eli Lilly Receives FDA Approval For Its Alzheimer’s Drug Kinsula
Eli Lilly & Co received approval for its Alzheimer’s drug from the Food & Drug Administration on Tuesday. The development is significant as it expands treatment options for the neurological disorder... 
Via Talk Markets
Exposures Product Safety
Tesla, Paramount Global, Annovis Bio, Eli Lilly, Amazon: Why These 5 Stocks Are On Investors' Radars Today
On Tuesday, the Dow Jones Industrial Average rose by 0.4%, closing at $39,331.85, while the S&P 500 also ended the day in positive territory. 
Via Benzinga
Topics Stocks
Exposures US Equities
Insights Into Eli Lilly and Co's Performance Versus Peers In Pharmaceuticals Sector
Via Benzinga
AMZN Stock Outlook: Amazon’s Next Growth Wave Could Make Early Investors Rich
After effectively eliminating a threat from low-cost Chinese e-commerce websites and Amazon stock remains attractive. 
Via InvestorPlace
Eli Lilly Snags Long-Awaited Alzheimer's Drug Approval, Rivaling Biogen, Eisai
The company is on deck to rival Biogen and Eisai's Leqembi. 
Via Investor's Business Daily
How Great Is It to Have Customers That Absolutely Love You and Plan to Never Leave You?
We also talk about weight loss drugs and sleep apnea, and other stock market news. 
Via The Motley Fool
Joe Biden Suggests Novo Nordisk, Eli Lilly To Lower Prices For Its Popular Obesity Drugs
American leaders push for lower drug prices, highlighting recent legislation and widespread support for affordable medications. The Inflation Reduction Act caps insulin costs and Medicare now... 
Via Benzinga
Topics Economy
Exposures Interest Rates
Novo, Lilly Dive After Biden Slams Duo For 'Unconscionably High' Drug Prices
The duo make weight-loss and diabetes drugs that sell for more than $1,000 a month before insurance kicks in. 
Via Investor's Business Daily
Pfizer Stock is Ready to Stage a Turnaround on GLP-1 Hopes
Pharmaceutical giant Pfizer Inc. (NYSE: PFE) has been trying to enter the weight-loss treatment trend dominated by GLP-1 drug makers like Ozempic and Wegovy 
Via MarketBeat
3 Under-the-Radar Biotech Stocks With Blockbuster Potential
Are you looking to boost your portfolio with the best under-the-radar biotech stocks? Here are the top three. 
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Sanofi Nears Decision on $1.6B Upgrade For Frankfurt Insulin Plant
Sanofi is set to invest up to $1.6 billion in its Frankfurt insulin production site, marking a significant win for Germany's healthcare sector. Recent investments by Daiichi Sankyo and Eli Lilly... 
Via Benzinga
Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
Global pharmaceutical giant Eli Lilly & Co. (NYSE: LLY) has made headlines with its leading GLP-1 weight loss drugs, Mounjaro and Zepbound. 
Via MarketBeat
Exposures Product Safety
Eli Lilly Soars To 52-Week High: Can The Momentum Continue?
Eli Lilly is up a remarkable 97.38% over the past year and 55.32% year-to-date. Strong technical indicators suggest continued momentum. 
Via Benzinga
Is Google Stock A Buy With Earnings Due, New CFO Waiting In The Wings?
Up big in 2024 on AI buzz, Google reports earnings in July with a new CFO set to take over. 
Via Investor's Business Daily
Topics Artificial Intelligence
Exposures Artificial Intelligence
Nvidia Among Biggest Stock Market Winners In 2024, But This Is No. 1
Several AI stocks among the S&P 500's best performers. 
Via Investor's Business Daily
Topics Artificial Intelligence Stocks
Exposures Artificial Intelligence US Equities
Want Decades of Passive Income? 2 Top Dividend Stocks to Buy Now and Hold Forever.
These stalwart companies could help you safely grow your wealth. 
Via The Motley Fool
2 Top Healthcare Stocks to Buy in June
Healthcare businesses tend to hold up through various economic cycles. 
Via The Motley Fool
Sound Investments: 3 Stocks to Buy for a Good Night’s Rest
The safe stocks to buy for a good night’s rest aren’t the kind you’re thinking about. Nonetheless, they do make worthwhile investments. 
Via InvestorPlace
This Is Massive News for Eli Lilly Investors
A panel of advisors to the Food and Drug Administration (FDA) recently recommended Eli Lilly's Alzheimer's candidate. 
Via The Motley Fool
3 Sectors That Could Get Slammed by Attempts to Reduce U.S. Debt
With Washington likely having to take steps to cut the U.S. deficit within the next few years, here are three sectors at risk. 
Via InvestorPlace
Eli Lilly Is Teaming Up With OpenAI. Here Are 3 Things Smart Investors Should Know.
Eli Lilly is the latest major pharmaceutical company to bring artificial intelligence (AI) to the healthcare sector. 
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
First Half 2024 -- That's A Wrap
With the first half of 2024 now behind us, here is a snapshot of asset class performance across the financial landscape using US-listed ETFs and other exchange-traded products. 
Via Talk Markets
Topics ETFs
The 3 Smartest Biotech Stocks to Buy With $5K Right Now
With global obesity numbers bursting at the seams, some of the smartest biotech stocks to buy are those with weight loss drugs. 
Via InvestorPlace
The 3 Smartest Healthcare Stocks to Buy With $1K Right Now
The healthcare stocks to buy deserve more respect from investors who seek top-level growth outside of the tech sector. 
Via InvestorPlace
The Top 3 Weight Loss Drug Stocks to Buy for Huge Gains
Consider buying shares in these pharma companies, each of which is a leader in the weight loss drug sector. 
Via InvestorPlace
Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030
These healthcare stocks have clear paths to growth over the next few years. 
Via The Motley Fool
Stock Split Watch: Is Eli Lilly Next?
Eli Lilly's revenue has climbed, thanks to high demand for its weight loss drugs. 
Via The Motley Fool
< Previous 1 2
...
18 19 20 21 22 23 24 25 26
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Sunnyvale.com & California Media Partners, LLC. All rights reserved.